Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$2.28B |
 |
MedtronicMDT |
-$77M |
 |
Edwards LifesciencesEW |
-$339M |
 |
Intuitive SurgicalISRG |
-$882M |
 |
RxSightRXST |
-$89M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Glaze Richard | Nov 21, 2025 | Sell | 257 | $41.21 | $11,000 |
| Garner Todd W | Nov 6, 2025 | Sell | 3,500 | $43 | $150,000 |
| Farkas Charles | Sep 12, 2025 | Sell | 1,103 | $53.535 | $59,000 |
| Farkas Charles | Sep 12, 2025 | Sell | 897 | $53.512 | $48,000 |
| Garner Todd W | Aug 7, 2025 | Sell | 598 | $52.45 | $31,000 |
| Farkas Charles | May 5, 2025 | Sell | 4,000 | $56.942 | $230,000 |
| Glaze Richard | Feb 11, 2025 | Sell | 257 | $65.3542 | $17,000 |
| Peters Stanley W III | Jun 14, 2024 | Sell | 4,000 | $71.82 | $290,000 |
| BRONSON DAVID M | May 13, 2024 | Buy | 1,350 | $72.09 | $97,000 |
| Schwarzentraub Barbara J | May 8, 2024 | Buy | 1,442 | $69.26 | $100,000 |
| Aronson Martha Goldberg | May 6, 2024 | Buy | 2,000 | $70.98 | $140,000 |
| Beyer Pat | Apr 30, 2024 | Buy | 3,000 | $68.3 | $200,000 |
FAQ - Insider Transactions
The most recent insider transaction for Conmed was conducted by Glaze Richard, who sold 257 shares on November 21, 2025 at a price of $41.21 per share.
Beyer Pat has bought the most CNMD stock in the last 2 years, with a total value of $200,000.
Farkas Charles has sold the most CNMD stock in the last 2 years, with a total value of $330,000.
The total value of insider transactions for Conmed in the last 2 years is negative, amounting to -$290,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Conmed have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
